Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06439056
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-08
First Post:
2024-05-16
Brief Title:
Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
Sponsor:
Nanexa AB
Organization:
Nanexa AB
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-27
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-11
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-16
First Submit QC Date:
May 31 2024
Study First Post Date:
2024-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-01
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL